RT Journal Article
SR Electronic
T1 Pulmonary hypertension and chronic lung disease: where are we headed?
JF European Respiratory Review
JO EUROPEAN RESPIRATORY REVIEW
FD European Respiratory Society
SP 190065
DO 10.1183/16000617.0065-2019
VO 28
IS 153
A1 Davide Elia
A1 Antonella Caminati
A1 Maurizio Zompatori
A1 Roberto Cassandro
A1 Chiara Lonati
A1 Francesca Luisi
A1 Giuseppe Pelosi
A1 Steeve Provencher
A1 Sergio Harari
YR 2019
UL http://err.ersjournals.com/content/28/153/190065.abstract
AB Pulmonary hypertension related to chronic lung disease, mainly represented by COPD and idiopathic pulmonary fibrosis, is associated with a worse outcome when compared with patients only affected by parenchymal lung disease. At present, no therapies are available to reverse or slow down the pathological process of this condition and most of the clinical trials conducted to date have had no clinically significant impact. Nevertheless, the importance of chronic lung diseases is always more widely recognised and, along with its increasing incidence, associated pulmonary hypertension is also expected to be growing in frequency and as a health burden worldwide. Therefore, it is desirable to develop useful and reliable tools to obtain an early diagnosis and to monitor and follow-up this condition, while new insights in the therapeutic approach are explored.New prospective in the management of pulmonary hypertension related to chronic lung diseases http://bit.ly/2lW4CfE